A method of treatment of obesity or diabetes mellitus in a warm-blooded animal requiring such treatment which comprises administering to said animal an effective amount of the compound N-(2-[2-hydroxy-3-phenoxypropyl]aminoethyl)-isobutyramide in racemic (R,S) or levorotatory optically active (S) form, or of a pharmaceutically acceptable acid-addition salt thereof.
-
(2008/06/13)
Pharmaceutical compositions
The invention includes novel pharmaceutical compositions for topical use in the therapy or prophylaxis of inflammatory skin diseases, a method of treating one or more such diseases, a novel, optically active N-substituted-isobutyramide as an active ingredient and a process for the manufacture of said novel active ingredient.
The synthesis of a series of 1-phenoxy-3-amino>-2-propanols is described.Many of the compounds are more potent than propanolol as β blockers, while having cardioselectivity comparable to that of practolol, when given intravenous
Large, M.S.,Smith, L.H.
p. 1286 - 1292
(2007/10/02)
ALKANOLAMINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
1-Aryloxy-3-aminoalkylamino-2-propanol derivatives, processes for their manufacture, pharmaceutical compositions containing them and methods of using them in the treatment of heart diseases. The compounds possess β-adrenergic blocking activity and some of
-
(2008/06/13)
ALKANOLAMINE DERIVATIVES
Novel 1-aryloxy-3-amidoalkylamino-2-propanol derivatives, processes for their manufacture, pharmaceutical compositions containing them and methods of using them in the treatment of heart diseases. The compounds possess β-adrenergic blocking activity and s
-
(2008/06/13)
More Articles about upstream products of 83029-57-6